Your browser doesn't support javascript.
loading
Corrigendum: Effects of Poria cocos extract on metabolic dysfunction-associated fatty liver disease via the FXR/PPARα-SREBPs pathway.
He, Jinbiao; Yang, Yu; Zhang, Fan; Li, Yanjuan; Li, Xiaosi; Pu, Xuemei; He, Xudong; Zhang, Mei; Yang, Xinxing; Yu, Qiuman; Qi, Yan; Li, Xuefang; Yu, Jie.
Afiliação
  • He J; College of Pharmaceutical Science, School of Clinical Medicine, Yunnan Key Laboratory of Southern Medicinal Utilization, Yunnan University of Chinese Medicine, Kunming, China.
  • Yang Y; College of Pharmaceutical Science, School of Clinical Medicine, Yunnan Key Laboratory of Southern Medicinal Utilization, Yunnan University of Chinese Medicine, Kunming, China.
  • Zhang F; College of Pharmaceutical Science, School of Clinical Medicine, Yunnan Key Laboratory of Southern Medicinal Utilization, Yunnan University of Chinese Medicine, Kunming, China.
  • Li Y; College of Pharmaceutical Science, School of Clinical Medicine, Yunnan Key Laboratory of Southern Medicinal Utilization, Yunnan University of Chinese Medicine, Kunming, China.
  • Li X; College of Pharmaceutical Science, School of Clinical Medicine, Yunnan Key Laboratory of Southern Medicinal Utilization, Yunnan University of Chinese Medicine, Kunming, China.
  • Pu X; College of Pharmaceutical Science, School of Clinical Medicine, Yunnan Key Laboratory of Southern Medicinal Utilization, Yunnan University of Chinese Medicine, Kunming, China.
  • He X; College of Pharmaceutical Science, School of Clinical Medicine, Yunnan Key Laboratory of Southern Medicinal Utilization, Yunnan University of Chinese Medicine, Kunming, China.
  • Zhang M; College of Pharmaceutical Science, School of Clinical Medicine, Yunnan Key Laboratory of Southern Medicinal Utilization, Yunnan University of Chinese Medicine, Kunming, China.
  • Yang X; College of Pharmaceutical Science, School of Clinical Medicine, Yunnan Key Laboratory of Southern Medicinal Utilization, Yunnan University of Chinese Medicine, Kunming, China.
  • Yu Q; College of Pharmaceutical Science, School of Clinical Medicine, Yunnan Key Laboratory of Southern Medicinal Utilization, Yunnan University of Chinese Medicine, Kunming, China.
  • Qi Y; College of Pharmaceutical Science, School of Clinical Medicine, Yunnan Key Laboratory of Southern Medicinal Utilization, Yunnan University of Chinese Medicine, Kunming, China.
  • Li X; College of Pharmaceutical Science, School of Clinical Medicine, Yunnan Key Laboratory of Southern Medicinal Utilization, Yunnan University of Chinese Medicine, Kunming, China.
  • Yu J; College of Pharmaceutical Science, School of Clinical Medicine, Yunnan Key Laboratory of Southern Medicinal Utilization, Yunnan University of Chinese Medicine, Kunming, China.
Front Pharmacol ; 14: 1172950, 2023.
Article em En | MEDLINE | ID: mdl-37274113
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Front Pharmacol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Front Pharmacol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China